These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Individualisation and "orphanization" in oncology]. Schenk M Dtsch Med Wochenschr; 2011 Apr; 136 Suppl 1():S27-30. PubMed ID: 21452104 [No Abstract] [Full Text] [Related]
4. Development trends for monoclonal antibody cancer therapeutics. Reichert JM; Valge-Archer VE Nat Rev Drug Discov; 2007 May; 6(5):349-56. PubMed ID: 17431406 [TBL] [Abstract][Full Text] [Related]
5. Two new indications for rituximab. Kahl BS Clin Adv Hematol Oncol; 2006 Dec; 4(12):901, 934. PubMed ID: 17235273 [No Abstract] [Full Text] [Related]
6. A magic bullet for cancer--how near and how far? Schnipper LE; Strom TB N Engl J Med; 2001 Jul; 345(4):283-4. PubMed ID: 11474668 [No Abstract] [Full Text] [Related]
7. Antibody-directed enzyme prodrug therapy. Connors TA Cancer Cells; 1990 Feb; 2(2):56-7. PubMed ID: 2397145 [No Abstract] [Full Text] [Related]
8. Antibody-drug conjugates for cancer: poised to deliver? Hughes B Nat Rev Drug Discov; 2010 Sep; 9(9):665-7. PubMed ID: 20811367 [No Abstract] [Full Text] [Related]
9. [Targeted drugs a chance for a better cure]. Bergh J; Jonsson B Lakartidningen; 2010 Apr 21-27; 107(16):1071-4. PubMed ID: 20476704 [No Abstract] [Full Text] [Related]
16. A new smart way to treat cancer. Johns Hopkins Med Lett Health After 50; 2003 Oct; 15(8):1-2, 7. PubMed ID: 14619801 [No Abstract] [Full Text] [Related]
17. [Intensive search for agents that knock out tumor growth]. Ostman A Lakartidningen; 2010 Apr 21-27; 107(16):1066-70. PubMed ID: 20476703 [No Abstract] [Full Text] [Related]
18. Bar the windows but open the door to randomization. Ratain MJ J Clin Oncol; 2010 Jul; 28(19):3104-6. PubMed ID: 20516430 [No Abstract] [Full Text] [Related]